Option Care Health, Inc. (OPCH)
Option Care Health, Inc. (OPCH) is a healthcare company (medical care facilities) based in the United States. The share price is $31.65, down 0.19% on the day, which values the company at $4.74B. Price as of 17 Nov 2026, 17:31 UTC, from Yahoo Finance.
Key facts
- Share price
- $31.65−0.19% today
- Market value
- $4.74B
- P/E ratio
- 22.9×last 12 months
- Forward P/E
- 15.2×
- Funk Score
- 55/100
- Against its own history
- About its usual priceusual price $31.61
- 200-week average
- $29.567% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Option Care Health, Inc. in more detail
OPCH trades at 22.9× its last twelve months' earnings, 15.2× next year's expected earnings, 0.8× sales. Measured against its own history, the price is 0% above what its usual multiples would imply ($31.61) — about its usual price. It sits 7% above its 200-week average of $29.56.
Over the last five fiscal years Option Care Health, Inc. has compounded revenue 13.3% a year, free cash flow 16.7% a year. Its Funk Score is 55 out of 100 (financial strength 4.6, profitability 3.8, growth 7.9, value 5.9, each out of 10).
In its favour: Altman Z in the safe zone; Share count keeps falling.
1 of the superinvestors tracked here hold OPCH, including Henry Ellenbogen (1.3% of the portfolio).
Superinvestors holding OPCH
1 of the investors tracked here report a position in their latest 13F filing.
- Henry Ellenbogen Durable Capital Partners1.26% of portfolio · $129.3M · trimmed · Q2 2026
Health Care companies of similar size
- Merit Medical SystemsMMSI
- Edgewise TherapeuticsEWTX
- LivaNovaLIVN
- Ionis PharmaceuticalsIONS
- Dianthus TherapeuticsDNTH
- MiniMed GroupMMED
- Adaptive BiotechnologiesADPT
- HeartflowHTFL
- CRISPR TherapeuticsCRSP
- Travere TherapeuticsTVTX
- Legend BiotechLEGN
- Definium TherapeuticsDFTX
Side by side:OPCH vs LEGN (Option Care Health, Inc. vs Legend Biotech)OPCH vs DFTX (Option Care Health, Inc. vs Definium Therapeutics)OPCH vs TVTX (Option Care Health, Inc. vs Travere Therapeutics)OPCH vs CRSP (Option Care Health, Inc. vs CRISPR Therapeutics)OPCH vs HTFL (Option Care Health, Inc. vs Heartflow)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Option Care Health, Inc. (OPCH): questions and answers
What is OPCH's P/E ratio?
Option Care Health, Inc. trades at 22.9× its last twelve months' earnings and 15.2× next year's expected earnings. At its fiscal year-ends over the past 9 years the P/E ranged from 6.1× to 85.9×, with a median of 25.1×.
What is OPCH's PEG ratio?
Option Care Health, Inc.'s PEG ratio is 1.49 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Option Care Health, Inc.'s market cap?
Option Care Health, Inc. is valued at $4.74B at a share price of $31.65.
Is OPCH overvalued or undervalued?
Against its own history, OPCH is about its usual price: the price is 0% above the $31.61 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is OPCH above its 200-week moving average?
Yes. OPCH is 7.1% above its 200-week average of $29.56. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Option Care Health, Inc. growing?
Over the last five fiscal years Option Care Health, Inc.'s revenue grew 13.3% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Option Care Health, Inc. (OPCH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OPCH
Underlying data: Yahoo Finance; company filings with the SEC.